← Evidence map

ArticleJournal of translational medicine2026

Exosome-delivered pepDCBLD2 promotes glucose metabolism to induce chemoresistance in colon cancer.

Xinyi Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 42665832